“We are licensed Pharmacists not drug dealers”
NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, IN THE SPIRIT OF JOSEPH SOLVO ESQ., IN THE SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., BEVERLY PRINCE MD., FACS., LEROY BAYLOR BS., WILLIE GUINYARD BS., IN THE SPIRIT OF BRAHM FISHER ESQ., JAY K. JOSHI MD., MBA, CYNTHIA B. JEFFERSON RN., JOSEPH WEBSTER MD., ESTER HYATT PH.D., MICHELE ALEXANDER MD., BERES E. MUSCHETT, STRATEGIC ADVISOR
“… it is so sad and heartbreaking that one’s race is still an integral part of how we value humans on the delivery of healthcare in America..”
norman j clement rph., dds owner pronto pharmacy:
MSNBC CHRIS HAYES CRITICAL RACE ON HEALTHCARE
New data shows just how much anti-Black structural racism impacts health
Duration: 05:16 8/5/2021
“This is what it looks like when people make the argument that race—anti-Black racism, in particular—is the central story in this country. These graphs show what that means, in a tangible way, for arguably the most important thing for all of us: how long we get to stay on this planet,” says MSNBC, Chris Hayes.
Thus, it appears the critical race concept is as applicable to both Law School and Medical training Programs (ie. Nursing, Pharmacy, Dentistry, and Medicine).
According to July 22, 2021, New England Journal of Medicine:
“The receipt of prescription opioid analgesics in the United States differs according to skin color despite a lack of evidence of racial differences in pain perception or in preferences for pain management.1,2 National, regional, and single-institution studies involving adults have consistently shown that Black and Hispanic patients are less likely to receive opioid analgesics than White patients.
When Black and Hispanic patients do receive opioids, they commonly receive a lower dose than their White counterparts.1-14 Studies have suggested that the differences may be narrowing, but their persistence raises disturbing questions about the effect of patient race on physicians’ pain-management decisions and, in turn, the suffering experienced by patients when they are undertreated or overtreated.” 1,15-18
RACIAL BIAS IN PAIN ASSESSMENT AND TREATMENT RECOMMENDATIONS, AND FALSE BELIEFS ABOUT BIOLOGICAL DIFFERENCES BETWEEN BLACKS AND WHITES
aDepartment of Psychology, University of Virginia, Charlottesville, VA, 22904;
bDepartment of Family Medicine, University of Virginia, Charlottesville, VA, 22908;
cDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, 22908
1To whom correspondence should be addressed. Email: firstname.lastname@example.org.
Edited by Susan T. Fiske, Princeton University, Princeton, NJ, and approved March 1, 2016 (received for review August 18, 2015)
Author contributions: K.M.H., S.T., J.R.A., and M.N.O. designed research; K.M.H. and M.N.O. performed research; K.M.H. and S.T. analyzed data; and K.M.H., S.T., J.R.A., and M.N.O. wrote the paper.
Kelly M. Hoffman, a,1 Sophie Trawalter, a Jordan R. Axt, a and M. Norman Oliver,c
“The present work examines beliefs associated with racial bias in pain management, a critical health care domain with well-documented racial disparities. Specifically, this work reveals that a substantial number of white laypeople and medical students, and residents hold false beliefs about biological differences between blacks and whites and demonstrates that these beliefs predict racial bias in pain perception and treatment recommendation accuracy.”
It also provides the first evidence that racial bias in pain perception is associated with racial bias in pain treatment recommendations. Taken together, this work provides evidence that false beliefs about biological differences between blacks and whites continue to shape the way we perceive and treat black people—they are associated with racial disparities in pain assessment and treatment recommendations.
Keywords: racial bias, pain perception, health care disparities, pain treatment
Black Americans are systematically undertreated for pain relative to white Americans. We examine whether this racial bias is related to false beliefs about biological differences between blacks and whites (e.g., “black people’s skin is thicker than white people’s skin”).”
As reported on July 22, 2021, New England Journal of Medicine, article called “Racial Inequality in Prescription Opioid Receipt-Role of Individuals Health Systems,” by Nancy E. Moden Md., Denna Chyn, M.P.H., Andrew Wood, M.P.H, and Ellen Meara, Ph.D., specifically these “false beliefs about biological differences between blacks and whites pointing out:
“Given the complicated trade-offs, we do not yet know which group has fared better overall, but it is hard to imagine that the influence of race in these decisions — given that there is no known physiologic basis — reflects high-quality, equitable care.2
Steep growth in the incidence of opioid overdose events among White patients in the United States has led some researchers and journalists to characterize unequal opioid receipt as protective for Black and Brown patients.18,23,25 Such characterizations ignore the risks of untreated and undertreated pain.1,26,27“
TO BE PROUD AND BRAVE
Study 1 documented these beliefs among white laypersons and revealed that participants who more strongly endorsed false beliefs about biological differences reported lower pain ratings for a black (vs. white) target.
Study 2 extended these findings to the medical context and found that half of a sample of white medical students and residents endorsed these beliefs. Moreover, participants who endorsed these beliefs rated the black (vs. white) patient’s pain as lower and made less accurate treatment recommendations. Participants who did not endorse these beliefs rated the black (vs. white) patient’s pain as higher, but showed no bias in treatment recommendations.”
“Thank you for speaking up on behalf of chronic pain patients and also acute pain patients. Unfortunately, another important side effect of this war on opioids is that surgical and post-surgical pain is being under-medicated by our doctors in hospitals, including some of our best hospitals in the country.
I am a chronic pain patient with a lifelong disease requiring many surgeries in my lifetime. I remember when the pain wasn’t managed well, the short period when it was given the importance of a vital sign, back to being under-medicated. I live in terror of having to have another surgery and have put off a needed surgery for well over a year now.“
TARGETTING OF LINCOURT PHARMACY BY UNITED STATES DRUG ENFORCEMENT (DEA)
Lincourt Pharmacy of Clearwater, Florida, has been in business for nearly 40 years. They are a specialty pharmacy in compounding sterile and non-sterile products, and we’re doing over $15 million per year with sales worldwide.
Louis Ladson, who is the pharmacist-owner, states that “his business dropped dramatically when the DEA came around and began targeting and harassing his wholesalers.” Let’s not be fooled. This is the work of Susan Langston and demonstrates how the DEA begins to target Black Own Pharmacy Businesses.
RACIAL INDIFFERENCE IS CORRUPTION
The origins of DEA are alarming that it was specifically formed by Richard Nixon to attack, disrupt and arrest leadership with the black community.
Chronologically, the civil rights and black liberation movements also dovetailed into the Vietnam war era.
As Nixon sought to tamp down dissent over a deeply unpopular war, two politically powerful non-establishment forces rose: Blacks and hippies. Criminalizing possession of drugs like heroin and marijuana was intended to “disrupt” two of the biggest anti-establishment forces that opposed Nixon, one of his top advisors later admitted.
TIME TO END THE WAR ON DRUGS AND HOW NPR BRYAN MANN EVEN GOT IT WRONG!!!
The racial indifference has prevented African American Pharmacy owners from operating a business in Florida. Had these practices been equally applied to White Own Pharmacies, there would be no operating pharmacies in Florida.
FOR NOW, YOU ARE WITHIN